Blood
ARTICLEThe Instability of the Membrane Skeleton in Thalassemic Red Blood Cells
MATERIALS AND METHODS
Materials.
Collection of blood.
Preparation of hemolysate.
SDS-polyacrylamide gel analysis (SDS-PAGE).
Western blot analysis.
Quantification of spectrin in the first hemolysate.
ELISA.
Table 2. Percentage of Spectrin in Hemolysate Determined by ELISA
| Disease Type | Hgb (g/dL) | Spectrin (%) |
| HbE/β-thal (NS) | 10.1 | 3.9 |
| HbE/β-thal (NS) | 7.9 | 6.2 |
| HbE/β-thal (NS) | 7.9 | 11.8 |
| HbE/β-thal (NS) | 6.4 | 4.6 |
| HbCS/CS | 9.8 | 2.3 |
| HbCS/CS | 10.6 | 2.6 |
| HbH/CS | 10.9 | 2.4 |
| HbH | 6.8 | 1.9 |
| HbH | 9.7 | 2.0 |
| NI | 16.6 | 1.3 |
| NI | 17.0 | 1.3 |
RESULTS
Spectrin content of first lysate.
Fig 1.. SDS-PAGE of first lysate of thalassemic samples from Bangkok (A and B). The RBCs were washed and lysed as described. One hundred fifty microliters of the first lysate was collected and solubilized in SDS, separated electrophoretically on 6% to 18% nonlinear gradient Polyacrylamide gels, and stained with Commassie blue.
Table 1. Diseases Studied
| Empty Cell | No |
|---|---|
| NI | 8 |
| AHA | 3 |
| Chemotherapy-induced anemia (AML) | 3 |
| SS | 2 |
| HbE/β-thal (S) | 3 |
| HbE/β-thal (NS) | 7 |
| Hb CS/CS | 7 |
| Hemoglobin H (α-thal-1/α-thal-2) | 5 |
| Hb H/CS | 5 |
| α-thal-1 trait | 3 |
Fig 2.. SDS-PAGE of samples from local and shipment controls. Patients samples included sickle cell anemia, autoimmunhemolytic anemia, and a patient with AML recovering from induction with an elevated reticulate count with no longer transfusion dependent.
Confirmation of the presence of spectrin.
Fig 3.. Western blotting studies of first lysates. After SDS-PAGE separations, the samples were transferred to nitrocellulose and reacted first with rabbit antispectrin antibodies and then with horseradish peroxidase-conjugated goat antirabbit antibodies. The immunoblots were developed using 4-chloronaphthol as substrate.
Quantification of the spectrin in the hemolysate.
Fig 4.. The amount of spectrin that dissociates from the membrane Is indicated for five specific thalassemic variants along with the patients’ hemoglobin content.
Detection of other membrane proteins in the first lysate.
Fig 5.. Western blotting studies of patients and control lysates. After SDS-PAGE separations, the samples were transferred to nitrocellulose and reacted first with antiactin monoclonal antibodies and then with peroxidase-conjugated goat antimouse antibodies. The immunoblots were developed using 4-chloronapthol as substrate.
Fig 6.. Western blotting studies of patients and control lysates. After SDS-PAGE separations, the samples were transferred to nitrocellulose and reacted first with affinity-purified anti-band 4.1 and then with peroxidase-conjugated goat antirabbit antibodies. The immunoblots were developed using 4-chloronapthol as substrate.
DISCUSSION
References
- 1Cellular and membrane properties of alpha and beta thalassemic erythrocytes are different: Implication for differences in clinical manifestationsBlood, 74 (1989), p. 2194
- 2Thalassemia: Pathophysiology of red cell changesAnnu Rev Med, 45 (1994), p. 211
- 3The relationship between in vivo generated hemoglobin skeletal protein complex and increased red cell membrane rigidityBlood, 71 (1988), p. 1427
- 4Erythrocyte membrane deformability and stability: Two distinct membrane properties that are independently regulated by skeletal protein associationsJ Cell Biol, 103 (1986), p. 343
- 5Molecular anatomy of the red blood cell membrane skeleton: Structure-function relationshipsSemin Hematol, 29 (1992), p. 231
- 6Uncoupling of the spectrin-based skeleton from the lipid bilayer in sickle red cellsScience, 252 (1991), p. 574
- 7Defective spectrin dimer self-association in thalassemic red cellsEur J Haematol, 38 (1987), p. 246
- 8Erythrocyte membrane skeleton abnormalities in severe beta thalassemiaBlood, 70 (1987), p. 158
- 9Differing erythrocyte membrane skeletal protein defects in alpha and beta thalassemiaJ Clin Invest, 83 (1989), p. 404
- 10Proteins involved in membrane-cytoskeleton association in human erythrocytes: Spectrin, ankyrin, and band 3Methods Enzymol, 96 (1983), p. 313
- 11Tissue- and development-specific alternative RNA splicing regulates expression of multiple isoforms of erythroid membrane protein 4.1J Biol Chem, 266 (1991), p. 8273
- 12Characterization and comparison of the red blood cell membrane damage in severe human alpha and beta thalassemiaBlood, 79 (1992), p. 1058
- 13Globin-chain specificity of oxidation-induced changes in red blood cell membrane propertiesBlood, 79 (1992), p. 1586
- 14Sulfhydryl reagents induce altered spectrin self-association, skeletal instability, and increased thermal sensitivity of red cellsBlood, 62 (1983), p. 1190
- 15Volume and cellular material properties of Hb-Constant Spring (CS)Blood, 82 (1993), p. 223a(abstr, supp 1)
- 16Biogenesis of normal and abnormal red blood cell membrane skeletonSemin Hematol, 29 (1992), p. 305
Cited by (55)
Molecular basis of α-thalassemia
2018, Blood Cells, Molecules, and DiseasesCitation Excerpt :The hemoglobinopathies are inherited as mostly autosomal recessive traits. The reduction or absence of α-globin chains result in an excess of unpaired beta (β)-like globin chains which form insoluble homotetramers leading to intracellular precipitation, ineffective erythropoiesis and acute hemolytic anemia typical for the severe forms of α-thalassemia [2,3]. Thalassemia patient studies have played a crucial role in the identification of numerous causative mutations in the globin genes, the upstream or downstream untranslated regions, and the regulatory elements controlling the expression of the α- and β-globin gene families and thus the hemoglobin switch.
The malaria-infected red blood cell: Structural and functional changes
2001, Advances in ParasitologyMore than a leak sealant. The mechanical properties of callose in pollen tubes
2005, Plant Physiology
- Supported by National Institutes of Health Grant No. ROI DK/3682, by European Community Grant No. EEC TS-CT92-0081, and by the Prajadhipok Rambhai Barni Foundation.Presented in abstract form at the 35th annual meeting of the American Society of Hematology, St Louis, MO, December 1993 (Blood 82:36Ia, 1993 [abstr, suppl I]).The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked “advertisement” in accordonce with 18 U.S.c. section 1734 solely to indicate this fact.